Imperial College London
Portrait Picture

DrJonathanKrell

Faculty of Medicine, Department of Surgery & Cancer

Clinical SL in Medical Oncology (Gynaecological Oncology)
 
 
 
//

Contact

 

j.krell

 
 
//

Location

 

Institute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Rizwan:2022:10.1136/jitc-2022-sitc2022.0427,
author = {Rizwan, N and Khaki, AR and Desai, A and Warner, J and Krell, J and Lythgoe, M},
doi = {10.1136/jitc-2022-sitc2022.0427},
publisher = {BMJ Publishing Group Ltd},
title = {427Approval timings and review speed of immune checkpoint inhibitors (ICIs) in cancer therapy between the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) from 2010-2022},
url = {http://dx.doi.org/10.1136/jitc-2022-sitc2022.0427},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Rizwan,N
AU  - Khaki,AR
AU  - Desai,A
AU  - Warner,J
AU  - Krell,J
AU  - Lythgoe,M
DO  - 10.1136/jitc-2022-sitc2022.0427
PB  - BMJ Publishing Group Ltd
PY  - 2022///
TI  - 427Approval timings and review speed of immune checkpoint inhibitors (ICIs) in cancer therapy between the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) from 2010-2022
UR  - http://dx.doi.org/10.1136/jitc-2022-sitc2022.0427
ER  -
Download